EA200601124A1 - Противовирусные фармацевтические композиции - Google Patents

Противовирусные фармацевтические композиции

Info

Publication number
EA200601124A1
EA200601124A1 EA200601124A EA200601124A EA200601124A1 EA 200601124 A1 EA200601124 A1 EA 200601124A1 EA 200601124 A EA200601124 A EA 200601124A EA 200601124 A EA200601124 A EA 200601124A EA 200601124 A1 EA200601124 A1 EA 200601124A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
virus pharmaceutical
present
virus
antiviral compositions
Prior art date
Application number
EA200601124A
Other languages
English (en)
Inventor
Эндрю Сянь Чэнь
Original Assignee
ЭсДи ФАРМАСЬЮТИКАЛЗ, ИНК.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЭсДи ФАРМАСЬЮТИКАЛЗ, ИНК. filed Critical ЭсДи ФАРМАСЬЮТИКАЛЗ, ИНК.
Publication of EA200601124A1 publication Critical patent/EA200601124A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Настоящее изобретение относится к противовирусной композиции, которая включает один или более компонент из числа ионного поливалентного металлического компонента, катионного полимера и катионного поверхностно-активного вещества. Настоящее изобретение также относится к способам получения и применения таких противовирусных композиций.
EA200601124A 2003-12-10 2004-12-08 Противовирусные фармацевтические композиции EA200601124A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52884303P 2003-12-10 2003-12-10
US11/003,302 US7968122B2 (en) 2003-12-10 2004-12-03 Anti-viral pharmaceutical compositions
PCT/US2004/041117 WO2005074947A2 (en) 2003-12-10 2004-12-08 Anti-viral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
EA200601124A1 true EA200601124A1 (ru) 2006-12-29

Family

ID=34840339

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601124A EA200601124A1 (ru) 2003-12-10 2004-12-08 Противовирусные фармацевтические композиции

Country Status (16)

Country Link
US (2) US7968122B2 (ru)
EP (1) EP1706122B1 (ru)
JP (1) JP2007513959A (ru)
KR (1) KR20060118573A (ru)
AT (1) ATE415166T1 (ru)
AU (1) AU2004315262A1 (ru)
BR (1) BRPI0417559A (ru)
CA (1) CA2549083A1 (ru)
DE (1) DE602004018032D1 (ru)
DK (1) DK1706122T3 (ru)
EA (1) EA200601124A1 (ru)
IL (1) IL176161A0 (ru)
MA (1) MA28334A1 (ru)
MX (1) MXPA06006650A (ru)
NO (1) NO20063147L (ru)
WO (1) WO2005074947A2 (ru)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2588782A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
CA2588802A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
EP1819225A2 (en) * 2004-12-09 2007-08-22 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
WO2006062845A2 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
US8088400B2 (en) * 2005-08-22 2012-01-03 Quick-Med Technologies, Inc. Disinfectant with quarternary ammonium polymer and copolymers
US20080000473A1 (en) * 2005-12-29 2008-01-03 Hugo Stephenson pH-Based Methods and Devices for Preventing Hemagglutinin Cell Membrane Fusion
ATE475424T1 (de) * 2006-04-04 2010-08-15 Marinomed Biotechnologie Gmbh Cellulosesulfat zur behandlung von rhinovirus- infektionen
EP1842546B1 (en) * 2006-04-04 2009-03-11 Marinomed Biotechnologie GmbH Cellulose sulfate for the treatment of rhinovirus infection
US20090238883A1 (en) * 2006-04-28 2009-09-24 Kren Betsy T Liver-specific nanocapsules and methods of using
WO2008054545A2 (en) * 2006-05-26 2008-05-08 The Dial Corporation Method of inhibiting the transmission of viruses
EP2040542A2 (en) * 2006-05-30 2009-04-01 The Dial Corporation Compositions having a high antiviral effeicacy
EP2034831A2 (en) * 2006-05-31 2009-03-18 The Dial Corporation Alcohol-containing antimicrobial compositions having improved efficacy
CA2654079A1 (en) 2006-06-02 2008-03-27 The Dial Corporation Method of inhibiting the transmission of influenza virus
CA2653383A1 (en) * 2006-06-05 2007-12-21 The Dial Corporation Methods and articles having a high antiviral and antibacterial efficacy
DE102006033167A1 (de) * 2006-07-10 2008-01-24 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
WO2008042891A2 (en) * 2006-10-02 2008-04-10 Oregan Biomedical Engineering Institute, Inc. Chitosan ophthalmic devices and methods
US20100173001A1 (en) * 2007-06-14 2010-07-08 Genesegues, Inc. Metal Ion-Treated Biocompatible Polymers Useful for Nanoparticles
CN101977625A (zh) * 2008-03-20 2011-02-16 克里斯特·坦诺 物质在制备治疗感冒药物中的应用
CN102088964B (zh) * 2008-07-07 2014-06-25 博磊科技股份有限公司 带静电荷的多功能鼻应用产品
JP2012526857A (ja) * 2009-05-16 2012-11-01 トルテック コーポレーション 静電的に帯電した多作用性経鼻適用、製品及び方法
JPWO2011142484A1 (ja) * 2010-05-14 2013-07-22 株式会社日本触媒 ポリアルキレンイミンを含むウイルス感染症治療薬
AU2012279764B2 (en) 2011-07-06 2015-08-13 Nbc Meshtec, Inc. Antiviral resin member
WO2013064805A1 (en) 2011-10-31 2013-05-10 The Premiere Polish Company Limited Personal care composition and a device for dispensing the same
WO2013168172A1 (en) 2012-05-10 2013-11-14 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
PL225045B1 (pl) * 2012-05-18 2017-02-28 Univ Jagiellonski Zastosowanie polimeru chitozanowego do wytwarzania leków do leczenia i profilaktyki infekcji wywołanych przez koronawirusy
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US20150018760A1 (en) * 2013-07-11 2015-01-15 Kathryn Morton HARDIN Nasal irrigation solution preparation system and method of preparation
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
WO2015072125A1 (ja) * 2013-11-14 2015-05-21 日本曹達株式会社 抗パルボウイルス組成物
NO342617B1 (no) * 2014-06-18 2018-06-18 Meda Otc Ab Oral formulering omfattende et antibakterielt middel for å forebygge og/eller behandle halitose, dårlig ånde, munntørrhet eller sår hals
WO2016036960A1 (en) 2014-09-03 2016-03-10 Genesegues, Inc. Therapeutic nanoparticles and related compositions, methods and systems
AR100459A1 (es) * 2015-05-15 2016-10-05 Química Luar S R L Una composición farmacéutica antiviral de uso tópico
JP6570316B2 (ja) * 2015-05-25 2019-09-04 ロート製薬株式会社 爪用組成物
US10293012B2 (en) 2017-05-04 2019-05-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods of using extracts of melissa officinalis against filoviruses
WO2018208739A1 (en) * 2017-05-08 2018-11-15 Thomas Cahill Pharmaceutical compositions comprising caffeic acid chelates
CN112351766A (zh) 2018-06-25 2021-02-09 璀昂芬制药公司 使用含锌的组合物抑制微生物感染的方法
US11369578B2 (en) * 2018-11-15 2022-06-28 Bluewillow Biologics, Inc. Persistent topical antimicrobial compositions and methods of using the same
CN114732822B (zh) * 2019-03-13 2023-06-30 中国人民解放军军事科学院军事医学研究院 氨基葡萄糖及其衍生物作为抗病毒药物的应用
EP3888629A1 (en) * 2020-03-31 2021-10-06 Dr. Kurt Wolff GmbH & Co. KG Composition for treatment or prevention of a virus infection
WO2021209493A2 (en) * 2020-04-15 2021-10-21 Solyplus Gmbh Means and methods of preventing and treating infections
US11690869B2 (en) * 2020-04-23 2023-07-04 Johnson & Johnson Consumer Inc. Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
US20210330698A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
KR102651711B1 (ko) * 2020-04-27 2024-03-27 조석형 항균 및 항바이러스제, 이의 제조방법 및 이로부터 제조된 보조사료
CA3192515A1 (en) * 2020-08-24 2022-03-03 Nanomerics Limited Viral inhibitors
EP3973966A1 (en) * 2020-09-24 2022-03-30 Dr. Kurt Wolff GmbH & Co. KG Hydroxyapatite composition for treatment and/or prevention of a virus infection
WO2022185326A1 (en) * 2021-03-03 2022-09-09 Amitava Mazumder Antiviral, anti sars-cov-2, anti h1n3, antibacterial and antimicrobial compositions and methods of preparation thereof
EP4324467A1 (en) * 2021-04-16 2024-02-21 Nippon Shokubai Co., Ltd. Anti-coronavirus agent
PT117220B (pt) 2021-05-11 2024-07-16 Inst Superior Tecnico Solução desinfetante compreendendo álcool e quitosano, processo para a sua obtenção e respetivos usos
WO2024135675A1 (ja) * 2022-12-22 2024-06-27 サンスター株式会社 抗インフルエンザウイルス用咽喉用組成物、及び咽喉用抗インフルエンザウイルス剤

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3404987A (en) * 1965-03-31 1968-10-08 Procter & Gamble Food preservative compositions and method for inhibiting microbial growth in food products
LU77562A1 (de) * 1977-06-17 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von neuen pharmazeutischen praeparaten
EP0012115A1 (de) 1978-12-04 1980-06-11 Ciba-Geigy Ag Pharmazeutische Präparate zur topischen Behandlung von Virusinfektionen
US4503070A (en) * 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
US4956385A (en) * 1981-07-31 1990-09-11 Eby Iii George A Method for reducing the duration of the common cold
AU553789B2 (en) * 1982-06-30 1986-07-24 Biorex Laboratories Ltd. Glycyrrhetinic acid derivatives in cream compositions
US4661354A (en) * 1984-06-21 1987-04-28 Finnerty Edmund F Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
EP0285357A3 (en) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Control of retroviruses
JP3095488B2 (ja) * 1991-10-30 2000-10-03 株式会社資生堂 噴霧用ゲル基剤およびそれを用いた噴霧用点鼻剤
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
EP0692253A4 (en) 1992-08-07 1998-06-03 Nippon Soda Co PROPHYLACTIC AGAINST MASTITIS IN PETS
US6321750B1 (en) * 1993-05-03 2001-11-27 Patrick D. Kelly Condom lubricants with zinc salts as anti-viral additives
FR2715300B1 (fr) * 1994-01-24 1996-03-29 Aromafarm Ltd Solution injectable de fluorure de benzalkonium et application à titre d'antiviral ou d'anti-infectieux.
HRP950149A2 (en) 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
SE518597C2 (sv) * 1994-05-04 2002-10-29 Medicarb Ab Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
JP3837769B2 (ja) 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
GB9525083D0 (en) * 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
US6344210B2 (en) * 1996-05-10 2002-02-05 Charles A. Fust Composition for freshening nostrils and sinus cavities
SE507028C2 (sv) * 1996-08-06 1998-03-16 Medicarb Ab Ny medicinsk användning
SE508760C2 (sv) 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
TW546151B (en) * 1997-07-23 2003-08-11 Senju Pharma Co Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
GB9725084D0 (en) * 1997-11-28 1998-01-28 Medeva Europ Ltd Vaccine compositions
US20020022660A1 (en) * 1998-01-20 2002-02-21 Hanuman B. Jampani Deep penetrating antimicrobial compositions
DE19818842C1 (de) * 1998-04-28 2000-01-05 Suedzucker Ag Erkältungsmittel
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
AU3565799A (en) 1998-09-17 2000-04-03 Zonagen, Inc. Methods and materials related to bioadhesive contraceptive gels
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US6423329B1 (en) * 1999-02-12 2002-07-23 The Procter & Gamble Company Skin sanitizing compositions
US20020151521A1 (en) * 1999-03-30 2002-10-17 Burke Peter A. Universal antiviral composition
US6570054B1 (en) * 1999-05-21 2003-05-27 The Procter & Gamble Company Absorbent article having a stable skin care composition
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
FR2801601B1 (fr) * 1999-11-26 2003-04-25 Rhodia Chimie Sa Complexe silicone reticulable thermiquement / adhesif dont l'interface possede une force de decollement modulable
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
JP2001271098A (ja) * 2000-03-24 2001-10-02 Lion Corp 電解洗浄水及びその製造方法、並びに、その電解洗浄水を用いる衣類又は食器の洗浄システム
US6638915B1 (en) * 2000-06-30 2003-10-28 Harold Killam Anti-viral composition
US20020136768A1 (en) * 2000-11-14 2002-09-26 Staats Victor J. Antimicrobial composition
CA2433037C (en) * 2000-12-28 2010-12-21 Takeda Chemical Industries, Ltd. Sustained-release preparation
EP1420642A2 (en) * 2001-07-02 2004-05-26 Surecide Technologies, LLC Novel synergistic antimicrobial compositions and methods
WO2003060003A1 (en) 2001-12-21 2003-07-24 E.I. Du Pont De Nemours And Company Antimicrobial solid surface materials containing chitosan-metal complexes
AU2003216213B2 (en) * 2002-02-07 2008-10-02 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
CN1708310A (zh) 2002-10-31 2005-12-14 朴来玉 抗癌或抗病毒组合物
WO2004080210A1 (en) 2003-03-14 2004-09-23 Boehringer Ingelheim Danmark A/S Compositions of dietary metals for support of the physiological intestinal development and prevention of diarrhoea
CN1267102C (zh) 2003-06-05 2006-08-02 广西半宙制药股份有限公司 一种具有抗病毒作用的复合物及其制备方法

Also Published As

Publication number Publication date
EP1706122B1 (en) 2008-11-26
AU2004315262A1 (en) 2005-08-18
NO20063147L (no) 2006-09-08
DK1706122T3 (da) 2009-03-23
WO2005074947A2 (en) 2005-08-18
KR20060118573A (ko) 2006-11-23
US7968122B2 (en) 2011-06-28
US8470346B2 (en) 2013-06-25
MXPA06006650A (es) 2007-01-26
EP1706122A2 (en) 2006-10-04
CA2549083A1 (en) 2005-08-18
MA28334A1 (fr) 2006-12-01
IL176161A0 (en) 2006-10-05
WO2005074947A3 (en) 2005-09-22
JP2007513959A (ja) 2007-05-31
ATE415166T1 (de) 2008-12-15
DE602004018032D1 (de) 2009-01-08
US20050232895A1 (en) 2005-10-20
BRPI0417559A (pt) 2007-03-27
US20110223259A1 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
EA200601124A1 (ru) Противовирусные фармацевтические композиции
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20074807L (no) Fast farmasoytisk doseringsformulering
DK2128246T3 (da) Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
TW200732349A (en) Anti-OX40L antibodies and methods using same
WO2007010034A3 (de) Ampholytisches copolymer, dessen herstellung und verwendung
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
WO2005005679A3 (en) Super-hydrophobic surfaces, methods of their construction and uses therefor
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
TW200501277A (en) Nanofiber surfaces for use in enhanced surface area applications
DE602005014628D1 (de) Embolie-teilchen
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
MY148075A (en) Vaccines against japanese encephalitis virus and west nile virus
SG130189A1 (en) Substituted indole-o-glucosides
BR0318477B1 (pt) dispositivo estabilizador de trocÂnter e dispositivo de atarraxamento coxo-femural.
WO2006007448A3 (en) Pharmaceutical co-crystal compositions and related methods of use
BR0214992A (pt) Artigo microfibrilado hidrofìlico, e, método para preparar o mesmo
WO2005011592A3 (en) Substituted indazole-o-glucosides
UA86042C2 (en) Substituted indazole-o-glucosides
WO2006026470A3 (en) Hiv immunostimulatory compositions
WO2006060189A3 (en) Curable silicone compositions incorporating a fluorescent detection system
DK1847611T3 (da) Rhamnose-inducerbart ekspressionssystem
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
BRPI0506631B8 (pt) combinações, composição farmacêutica e usos das combinações
DE60209359D1 (de) Lösungsmittelverklebungsverfahren